GlassScriptPhysician profile
Jane Duffy-Weisser
NPI 1699930529
$871.20
in general payments reported to CMS, 2019-2025
11 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.97 · 2022: $261 · 2023: $49.46 · 2024: $118 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $201.72 | 2024-2025 | |
| Lilly USA, LLC | $165.62 | 2022-2023 | Verzenio |
| Daiichi Sankyo INC. | $127.20 | 2022-2025 | Enhertu |
| Merck Sharp & Dohme LLC | $99.68 | 2021-2024 | Keytruda |
| Stemline Therapeutics INC. | $70.28 | 2025 | Orserdu |
| Amgen INC. | $54.61 | 2021-2022 | |
| Seagen INC. | $41.00 | 2021 | |
| Emd Serono, INC. | $30.58 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $30.55 | 2025 | Calquence |
| Pfizer INC. | $28.40 | 2022 | |
| Chiesi USA, INC. | $21.56 | 2024 | Ferriprox |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Duffy-Weisser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.